Dapagliflozin in Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Dapagliflozin
Related studies linked through entity extraction aliases.
Effect of Dapagliflozin Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Phase III Insulin Add-On Asia Regional Program - ST
- Status
- COMPLETED
- Phase
- PHASE3
Bioequivalence/Food Effect - Saxa/Dapa Dual Fixed Dose Combination (FDC)
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Compare the Pharmacodynamics of Canagliflozin and Dapagliflozin in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
- Status
- COMPLETED
- Phase
- PHASE1
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/Action
- Status
- COMPLETED
- Phase
- NA
Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea
- Status
- COMPLETED
- Phase
- PHASE3
Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Efficacy and Safety of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Diet and Exercise Alone
- Status
- SUSPENDED
- Phase
- PHASE3
Evaluation of Dapagliflozin Taken Twice-daily
- Status
- COMPLETED
- Phase
- PHASE3
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
- Status
- COMPLETED
- Phase
- PHASE3
Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus (T2DM)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker
- Status
- COMPLETED
- Phase
- PHASE3